Department of Neurosurgery, Osaka Medical Center for Cancer and Cardiovascular Diseases;
Departments of 2 Neurosurgery.
J Neurosurg. 2016 Nov;125(5):1136-1142. doi: 10.3171/2015.11.JNS151848. Epub 2016 Feb 26.
OBJECTIVE Diffusion MRI is attracting increasing interest for tissue characterization of gliomas, especially after the introduction of antiangiogenic therapy to treat malignant gliomas. The goal of the current study is to elucidate the actual magnitude of the correlation between diffusion MRI and cell density within the tissue. The obtained results were further extended and compared with metabolic imaging with C-methionine (MET) PET. METHODS Ninety-eight tissue samples from 37 patients were stereotactically obtained via an intraoperative neuronavigation system. Diffusion tensor imaging (DTI) and MET PET were performed as routine presurgical imaging studies for these patients. DTI was converted into fractional anisotropy (FA) and apparent diffusion coefficient (ADC) maps, and MET PET images were registered to Gd-administered T1-weighted images that were used for navigation. Metrics of FA, ADC, and tumor-to-normal tissue ratio of MET PET along with relative values of FA (rFA) and ADC (rADC) compared with normal-appearing white matter were correlated with cell density of the stereotactically obtained tissues. RESULTS rADC was significantly lower in lesions obtained from Gd-enhancing lesions than from nonenhancing lesions. Although rADC showed a moderate but statistically significant negative correlation with cell density (p = 0.010), MET PET showed a superb positive correlation with cell density (p < 0.0001). On the other hand, rFA showed little correlation with cell density. CONCLUSIONS The presented data validated the use of rADC for estimating the treatment response of gliomas but also caution against overestimating its limited accuracy compared with MET PET.
扩散 MRI 技术在脑胶质瘤的组织特征分析中受到越来越多的关注,尤其是在引入抗血管生成疗法治疗恶性脑胶质瘤之后。本研究的目的是阐明扩散 MRI 与组织内细胞密度之间实际关联的幅度。进一步扩展了获得的结果,并与 C-蛋氨酸(MET)PET 代谢成像进行了比较。
37 名患者的 98 个组织样本通过术中神经导航系统进行立体定向获取。扩散张量成像(DTI)和 MET PET 是这些患者常规术前成像研究的一部分。将 DTI 转换为各向异性分数(FA)和表观扩散系数(ADC)图,并将 MET PET 图像与 Gd 给药的 T1 加权图像配准,这些图像用于导航。FA、ADC 以及 MET PET 的肿瘤与正常组织比值的指标,以及与正常白质相比的 FA(rFA)和 ADC(rADC)的相对值,与立体定向获取的组织的细胞密度相关。
与非增强病变相比,增强病变中获得的 rADC 值明显较低。尽管 rADC 与细胞密度呈中度但具有统计学意义的负相关(p = 0.010),但 MET PET 与细胞密度呈极好的正相关(p < 0.0001)。另一方面,rFA 与细胞密度相关性较小。
所提供的数据验证了 rADC 用于估计脑胶质瘤治疗反应的用途,但也警告不要高估其与 MET PET 相比的有限准确性。